Spi-1, Fli-1 and Fli-3 (miR-17-92) Oncogenes Contribute to a Single Oncogenic Network Controlling Cell Proliferation in Friend Erythroleukemia

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Kayali, Samer ^a   Giraud, Guillaume ^a,b   Morlé, François ^a   Guyot, Boris ^a  

^a UNIVERSITÉ LYON 1   (France)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICRORNA; TRANSCRIPTION FACTOR FLI 1; TRANSCRIPTION FACTOR FLI 3; TRANSCRIPTION FACTOR SPI 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOGENESIS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DEREGULATION; DNA BINDING; ERYTHROLEUKEMIA; GENE LOCUS; GENE TARGETING; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE FLI 1; ONCOGENE FLI 3; ONCOGENE SPI 1; PROMOTER REGION; RIBOSOME;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; MICRORNAS; PEPTIDES; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-FLI-1;

EID: 84867304399     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046799     Document Type: Article

References (56)

1. Ciriello G, Cerami E, Sander C, Schultz N, (2012) Mutual exclusivity analysis identifies oncogenic network modules. Genome Res 22: 398-406.
2. Lee CR, Cervi D, Truong AH, Li YJ, Sarkar A, et al. (2003) Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia. Anticancer Res 23: 2159-2166.
3. Moreau-Gachelin F, (2008) Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation. Retrovirology 5: 99.
4. Blair DG, Athanasiou M, (2000) Ets and retroviruses- transduction and activation of members of the Ets oncogene family in viral oncogenesis. Oncogene 19: 6472-6481.
5. Cui JW, Li YJ, Sarkar A, Brown J, Tan YH, et al. (2007) Retroviral insertional activation of the Fli-3 locus in erythroleukemias encoding a cluster of microRNAs that convert Epo-induced differentiation to proliferation. Blood 110: 2631-2640.
6. Hollenhorst PC, McIntosh LP, Graves BJ, (2011) Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 80: 437-471.
7. Starck J, Doubeikovski A, Sarrazin S, Gonnet C, Rao G, et al. (1999) Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines. Mol Cell Biol 19: 121-135.
8. Ano S, Pereira R, Pironin M, Lesault I, Milley C, et al. (2004) Erythroblast transformation by FLI-1 depends upon its specific DNA binding and transcriptional activation properties. J Biol Chem 279: 2993-3002.
9. Cui JW, Vecchiarelli-Federico LM, Li YJ, Wang GJ, Ben-David Y, (2009) Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia. Leukemia 23: 1311-1319.
10. Papetti M, Skoultchi AI, (2007) Reprogramming leukemia cells to terminal differentiation and growth arrest by RNA interference of PU.1. Mol Cancer Res 5: 1053-1062.
11. Rimmele P, Kosmider O, Mayeux P, Moreau-Gachelin F, Guillouf C, (2007) Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation. Blood 109: 3007-3014.
12. Burda P, Laslo P, Stopka T, (2010) The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis. Leukemia 24: 1249-1257.
13. Starck J, Cohet N, Gonnet C, Sarrazin S, Doubeikovskaia Z, et al. (2003) Functional cross-antagonism between transcription factors FLI-1 and EKLF. Mol Cell Biol 23: 1390-1402.
14. Pereira R, Quang CT, Lesault I, Dolznig H, Beug H, et al. (1999) FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene 18: 1597-1608.
15. Truong AH, Cervi D, Lee J, Ben-David Y, (2005) Direct transcriptional regulation of MDM2 by Fli-1. Oncogene 24: 962-969.
16. Lakhanpal GK, Vecchiarelli-Federico LM, Li YJ, Cui JW, Bailey ML, et al. (2010) The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis. Blood 116: 428-436.
17. Choe KS, Ujhelly O, Wontakal SN, Skoultchi AI, (2010) PU.1 directly regulates cdk6 gene expression, linking the cell proliferation and differentiation programs in erythroid cells. J Biol Chem 285: 3044-3052.
18. Juban G, Giraud G, Guyot B, Belin S, Diaz JJ, et al. (2009) Spi-1 and Fli-1 directly activate common target genes involved in ribosome biogenesis in Friend erythroleukemic cells. Mol Cell Biol 29: 2852-2864.
19. Mendell JT, (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
20. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
21. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, et al. (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065.
22. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, et al. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9: 405-414.
23. Xiang J, Wu J, (2010) Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis. Curr Genomics 11: 129-135.
24. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, et al. (2009) miR-19 is a key oncogenic component of mir-17-92. Genes Dev 23: 2839-2849.
25. Olive V, Jiang I, He L, (2010) mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42: 1348-1354.
26. van Haaften G, Agami R, (2010) Tumorigenicity of the miR-17-92 cluster distilled. Genes Dev 24: 1-4.
27. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, et al. (2010) microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A 107: 8231-8236.
28. Shan SW, Lee DY, Deng Z, Shatseva T, Jeyapalan Z, et al. (2009) MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol 11: 1031-1038.
29. Li Y, Vecchiarelli-Federico LM, Li YJ, Egan SE, Spaner D, et al. (2012) The miR-17-92 cluster expands multipotent hematopoietic progenitors while imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice. Blood 119: 4486-4498.
30. Friend C, Scher W, Holland JG, Sato T, (1971) Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci U S A 68: 378-382.
31. Singer D, Cooper M, Maniatis GM, Marks PA, Rifkind RA, (1974) Erythropoietic differentiation in colonies of cells transformed by Friend virus. Proc Natl Acad Sci U S A 71: 2668-2670.
32. Choppin J, Casadevall N, Lacombe C, Wendling F, Goldwasser E, et al. (1985) Production of erythropoietin by cloned malignant murine erythroid cells. Exp Hematol 13: 610-615.
33. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
34. Ji M, Rao E, Ramachandrareddy H, Shen Y, Jiang C, et al. (2011) The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies. Am J Pathol 179: 1645-1656.
35. Dweep H, Sticht C, Pandey P, Gretz N, (2011) miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 44: 839-847.
36. Zhan M, Miller CP, Papayannopoulou T, Stamatoyannopoulos G, Song CZ, (2007) MicroRNA expression dynamics during murine and human erythroid differentiation. Exp Hematol 35: 1015-1025.
37. Li H, Bian C, Liao L, Li J, Zhao RC, (2011) miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat 126: 565-575.
38. Pospisil V, Vargova K, Kokavec J, Rybarova J, Savvulidi F, et al. (2011) Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation. EMBO J 30: 4450-4464.
39. Barnache S, Wendling F, Lacombe C, Denis N, Titeux M, et al. (1998) Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation. Oncogene 16: 2989-2995.
40. Sampson EM, Haque ZK, Ku MC, Tevosian SG, Albanese C, et al. (2001) Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. EMBO J 20: 4500-4511.
41. Chen YC, Zhang XW, Niu XH, Xin DQ, Zhao WP, et al. (2010) Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer. Oncogene 29: 3067-3078.
42. Escamilla-Powers JR, Daniel CJ, Farrell A, Taylor K, Zhang X, et al. (2010) The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity. J Biol Chem 285: 4847-4858.
43. Campaner S, Amati B, (2012) Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance. Cell Div 7: 6.
44. Zhuo de X, Niu XH, Chen YC, Xin DQ, Guo YL, et al. (2010) Vitamin D3 up-regulated protein 1(VDUP1) is regulated by FOXO3A and miR-17-5p at the transcriptional and post-transcriptional levels, respectively, in senescent fibroblasts. J Biol Chem 285: 31491-31501.
45. Trompeter HI, Abbad H, Iwaniuk KM, Hafner M, Renwick N, et al. (2011) MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS One 6: e16138.
46. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, et al. (2007) An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282: 2135-2143.
47. Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, et al. (2008) Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 3: e2236.
48. Kedde M, van Kouwenhove M, Zwart W, Oude Vrielink JA, Elkon R, et al. (2010) A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility. Nat Cell Biol 12: 1014-1020.
49. Challagundla KB, Sun XX, Zhang X, DeVine T, Zhang Q, et al. (2011) Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress. Mol Cell Biol 31: 4007-4021.
50. Ebert MS, Sharp PA, (2010) Emerging roles for natural microRNA sponges. Curr Biol 20: R858-861.
51. Bradshaw S, Zheng WJ, Tsoi LC, Gilkeson G, Zhang XK, (2008) A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis. Clin Immunol 129: 19-30.
52. Morris EE, Amria MY, Kistner-Griffin E, Svenson JL, Kamen DL, et al. (2010) A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis. Arthritis Res Ther 12: R212.
53. Zhang XK, Gallant S, Molano I, Moussa OM, Ruiz P, et al. (2004) Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. J Immunol 173: 6481-6489.
54. Dai R, Zhang Y, Khan D, Heid B, Caudell D, et al. (2010) Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One 5: e14302.
55. Sakurai T, Kondoh N, Arai M, Hamada J, Yamada T, et al. (2007) Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy. Cancer Sci 98: 1775-1784.
56. Rostad K, Mannelqvist M, Halvorsen OJ, Oyan AM, Bo TH, et al. (2007) ERG upregulation and related ETS transcription factors in prostate cancer. Int J Oncol 30: 19-32.